Clinical trial
The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke
NCT07347327 is registered in ClinicalTrials.gov with Ke Dong, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke
- Lead sponsor
- Ke Dong, MD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- December 29, 2025
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.